10-Q Filing

AGIOS PHARMACEUTICALS, INC. CIK: 1439222 Q3 2024

Filing Information

Form Type	10-Q
Accession Number	`0001439222-24-000138`
Period End Date	20240930
Filing Date	20241031
Fiscal Year	2024
Fiscal Period	Q3
XBRL Instance	agio-20240930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 156 Income Statement 144 Cash Flow Statement 164 Stockholders Equity 102 Comprehensive Income 32

Balance Sheet 156 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, authorized (in shares)	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, authorized (in shares)	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, authorized (in shares)	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, authorized (in shares)	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$253.73M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$253.73M	USD	Point-in-time
Preferred stock, issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$88.20M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$88.20M	USD	Point-in-time
Preferred stock, issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$751.03M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$751.03M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$688.72M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$688.72M	USD	Point-in-time
Preferred stock, outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable, net	`ContractWithCustomerAssetNetCurrent`	$3.12M	USD	Point-in-time
Accounts receivable, net	`ContractWithCustomerAssetNetCurrent`	$3.12M	USD	Point-in-time
Accounts receivable, net	`ContractWithCustomerAssetNetCurrent`	$2.81M	USD	Point-in-time
Accounts receivable, net	`ContractWithCustomerAssetNetCurrent`	$2.81M	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory	`InventoryNet`	$26.43M	USD	Point-in-time
Inventory	`InventoryNet`	$26.43M	USD	Point-in-time
Inventory	`InventoryNet`	$19.08M	USD	Point-in-time
Inventory	`InventoryNet`	$19.08M	USD	Point-in-time
Common stock, authorized (in shares)	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Common stock, authorized (in shares)	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Common stock, authorized (in shares)	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Common stock, authorized (in shares)	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Common stock, issued (in shares)	`CommonStockSharesIssued`	72.16M	shares	Point-in-time
Common stock, issued (in shares)	`CommonStockSharesIssued`	72.16M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$35.02M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$35.02M	USD	Point-in-time
Common stock, issued (in shares)	`CommonStockSharesIssued`	73.24M	shares	Point-in-time
Common stock, issued (in shares)	`CommonStockSharesIssued`	73.24M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$39.88M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$39.88M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$833.84M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$833.84M	USD	Point-in-time
Common stock, outstanding (in shares)	`CommonStockSharesOutstanding`	55.95M	shares	Point-in-time
Common stock, outstanding (in shares)	`CommonStockSharesOutstanding`	55.95M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.07B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.07B	USD	Point-in-time
Common stock, outstanding (in shares)	`CommonStockSharesOutstanding`	57.02M	shares	Point-in-time
Common stock, outstanding (in shares)	`CommonStockSharesOutstanding`	57.02M	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$655.89M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$655.89M	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Treasury stock (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$29.43M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$29.43M	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Treasury stock (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Operating lease assets	`OperatingLeaseRightOfUseAsset`	$45.84M	USD	Point-in-time
Operating lease assets	`OperatingLeaseRightOfUseAsset`	$45.84M	USD	Point-in-time
Operating lease assets	`OperatingLeaseRightOfUseAsset`	$54.41M	USD	Point-in-time
Operating lease assets	`OperatingLeaseRightOfUseAsset`	$54.41M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$15.38M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$15.38M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$11.82M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$11.82M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$4.06M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$4.06M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$4.06M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$4.06M	USD	Point-in-time
Total assets	`Assets`	$937.12M	USD	Point-in-time
Total assets	`Assets`	$937.12M	USD	Point-in-time
Total assets	`Assets`	$1.79B	USD	Point-in-time
Total assets	`Assets`	$1.79B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$9.78M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$9.78M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$17.14M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$17.14M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$33.31M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$33.31M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$43.17M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$43.17M	USD	Point-in-time
Income tax payable	`TaxesPayableCurrent`	-	USD	Point-in-time
Income tax payable	`TaxesPayableCurrent`	-	USD	Point-in-time
Income tax payable	`TaxesPayableCurrent`	$52.68M	USD	Point-in-time
Income tax payable	`TaxesPayableCurrent`	$52.68M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$15.01M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$15.01M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$16.32M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$16.32M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$119.45M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$119.45M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$67.95M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$67.95M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$56.99M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$56.99M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$44.52M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$44.52M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.16M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.16M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.16M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.16M	USD	Point-in-time
Total liabilities	`Liabilities`	$165.12M	USD	Point-in-time
Total liabilities	`Liabilities`	$165.12M	USD	Point-in-time
Total liabilities	`Liabilities`	$126.10M	USD	Point-in-time
Total liabilities	`Liabilities`	$126.10M	USD	Point-in-time
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at September 30, 2024 and December 31, 2023	`PreferredStockValueOutstanding`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at September 30, 2024 and December 31, 2023	`PreferredStockValueOutstanding`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at September 30, 2024 and December 31, 2023	`PreferredStockValueOutstanding`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at September 30, 2024 and December 31, 2023	`PreferredStockValueOutstanding`	-	USD	Point-in-time
Common stock, $0.001 par value; 125,000,000 shares authorized; 73,237,954 shares issued and 57,021,543 shares outstanding at September 30, 2024, and 72,161,489 shares issued and 55,945,078 shares outstanding at December 31, 2023	`CommonStockValueOutstanding`	$73.00K	USD	Point-in-time
Common stock, $0.001 par value; 125,000,000 shares authorized; 73,237,954 shares issued and 57,021,543 shares outstanding at September 30, 2024, and 72,161,489 shares issued and 55,945,078 shares outstanding at December 31, 2023	`CommonStockValueOutstanding`	$73.00K	USD	Point-in-time
Common stock, $0.001 par value; 125,000,000 shares authorized; 73,237,954 shares issued and 57,021,543 shares outstanding at September 30, 2024, and 72,161,489 shares issued and 55,945,078 shares outstanding at December 31, 2023	`CommonStockValueOutstanding`	$72.00K	USD	Point-in-time
Common stock, $0.001 par value; 125,000,000 shares authorized; 73,237,954 shares issued and 57,021,543 shares outstanding at September 30, 2024, and 72,161,489 shares issued and 55,945,078 shares outstanding at December 31, 2023	`CommonStockValueOutstanding`	$72.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.44B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.44B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.48B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.48B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-441.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-441.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$3.42M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$3.42M	USD	Point-in-time
Treasury stock, at cost (16,216,411 shares at September 30, 2024 and December 31, 2023)	`TreasuryStockValue`	$802.49M	USD	Point-in-time
Treasury stock, at cost (16,216,411 shares at September 30, 2024 and December 31, 2023)	`TreasuryStockValue`	$802.49M	USD	Point-in-time
Treasury stock, at cost (16,216,411 shares at September 30, 2024 and December 31, 2023)	`TreasuryStockValue`	$802.49M	USD	Point-in-time
Treasury stock, at cost (16,216,411 shares at September 30, 2024 and December 31, 2023)	`TreasuryStockValue`	$802.49M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-52.40M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-52.40M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-822.65M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-822.65M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$964.24M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$964.24M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.10B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.10B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.04B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.04B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.63B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.63B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$743.92M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$743.92M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$886.84M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$886.84M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$660.51M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$660.51M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$811.02M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$811.02M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$937.12M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$937.12M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.79B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.79B	USD	Point-in-time

Income Statement 144 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$19.72M	USD	3 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$19.72M	USD	3 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$25.77M	USD	3 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$25.77M	USD	3 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$8.96M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$8.96M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$7.40M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$7.40M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$2.29M	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$2.29M	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$2.90M	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$2.90M	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$783.00K	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$783.00K	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$633.00K	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$633.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$218.04M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$218.04M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$218.48M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$218.48M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$72.45M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$72.45M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$81.84M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$81.84M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$84.60M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$84.60M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$25.82M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$25.82M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$105.09M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$105.09M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$38.54M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$38.54M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$304.93M	USD	3 Qtrs
Total operating expenses	`CostsAndExpenses`	$304.93M	USD	3 Qtrs
Total operating expenses	`CostsAndExpenses`	$111.78M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$111.78M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$326.47M	USD	3 Qtrs
Total operating expenses	`CostsAndExpenses`	$326.47M	USD	3 Qtrs
Total operating expenses	`CostsAndExpenses`	$108.30M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$108.30M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-100.90M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-100.90M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-300.70M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-300.70M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-102.81M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-102.81M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-285.21M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-285.21M	USD	3 Qtrs
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	-	USD	1 Quarter
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	-	USD	1 Quarter
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	$889.14M	USD	1 Quarter
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	$889.14M	USD	1 Quarter
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	-	USD	3 Qtrs
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	-	USD	3 Qtrs
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	$889.14M	USD	3 Qtrs
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	$889.14M	USD	3 Qtrs
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	$200.00M	USD	3 Qtrs
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	$200.00M	USD	3 Qtrs
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	$200.00M	USD	1 Quarter
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	$200.00M	USD	1 Quarter
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	-	USD	3 Qtrs
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	-	USD	3 Qtrs
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNonoperatingNet`	$24.72M	USD	3 Qtrs
Interest income, net	`InterestIncomeExpenseNonoperatingNet`	$24.72M	USD	3 Qtrs
Interest income, net	`InterestIncomeExpenseNonoperatingNet`	$30.07M	USD	3 Qtrs
Interest income, net	`InterestIncomeExpenseNonoperatingNet`	$30.07M	USD	3 Qtrs
Interest income, net	`InterestIncomeExpenseNonoperatingNet`	$8.38M	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNonoperatingNet`	$8.38M	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNonoperatingNet`	$13.06M	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNonoperatingNet`	$13.06M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$4.86M	USD	3 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$4.86M	USD	3 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$1.65M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$1.65M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$1.20M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$1.20M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$4.34M	USD	3 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$4.34M	USD	3 Qtrs
Net income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-256.15M	USD	3 Qtrs
Net income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-256.15M	USD	3 Qtrs
Net income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$823.37M	USD	3 Qtrs
Net income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$823.37M	USD	3 Qtrs
Net income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-91.32M	USD	1 Quarter
Net income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-91.32M	USD	1 Quarter
Net income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.00B	USD	1 Quarter
Net income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.00B	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$53.12M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$53.12M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$53.12M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$53.12M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-91.32M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-91.32M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-96.12M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-96.12M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$947.91M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$947.91M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-81.02M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-81.02M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-81.55M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-81.55M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$770.25M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$770.25M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-83.81M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-83.81M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-256.15M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-256.15M	USD	3 Qtrs
Net income (loss) per share - basic (in usd per share)	`EarningsPerShareBasic`	$-1.64	USD	1 Quarter
Net income (loss) per share - basic (in usd per share)	`EarningsPerShareBasic`	$-1.64	USD	1 Quarter
Net income (loss) per share - basic (in usd per share)	`EarningsPerShareBasic`	$16.65	USD	1 Quarter
Net income (loss) per share - basic (in usd per share)	`EarningsPerShareBasic`	$16.65	USD	1 Quarter
Net income (loss) per share - basic (in usd per share)	`EarningsPerShareBasic`	$-4.61	USD	3 Qtrs
Net income (loss) per share - basic (in usd per share)	`EarningsPerShareBasic`	$-4.61	USD	3 Qtrs
Net income (loss) per share - basic (in usd per share)	`EarningsPerShareBasic`	$13.58	USD	3 Qtrs
Net income (loss) per share - basic (in usd per share)	`EarningsPerShareBasic`	$13.58	USD	3 Qtrs
Net income (loss) per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$-4.61	USD	3 Qtrs
Net income (loss) per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$-4.61	USD	3 Qtrs
Net income (loss) per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$16.22	USD	1 Quarter
Net income (loss) per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$16.22	USD	1 Quarter
Net income (loss) per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$-1.64	USD	1 Quarter
Net income (loss) per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$-1.64	USD	1 Quarter
Net income (loss) per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$13.38	USD	3 Qtrs
Net income (loss) per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$13.38	USD	3 Qtrs
Weighted-average number of common shares used in computing net income (loss) per share - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	56.71M	shares	3 Qtrs
Weighted-average number of common shares used in computing net income (loss) per share - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	56.71M	shares	3 Qtrs
Weighted-average number of common shares used in computing net income (loss) per share - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	55.56M	shares	3 Qtrs
Weighted-average number of common shares used in computing net income (loss) per share - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	55.56M	shares	3 Qtrs
Weighted-average number of common shares used in computing net income (loss) per share - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	56.94M	shares	1 Quarter
Weighted-average number of common shares used in computing net income (loss) per share - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	56.94M	shares	1 Quarter
Weighted-average number of common shares used in computing net income (loss) per share - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	55.80M	shares	1 Quarter
Weighted-average number of common shares used in computing net income (loss) per share - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	55.80M	shares	1 Quarter
Weighted-average number of common shares used in computing net income (loss) per share diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	55.56M	shares	3 Qtrs
Weighted-average number of common shares used in computing net income (loss) per share diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	55.56M	shares	3 Qtrs
Weighted-average number of common shares used in computing net income (loss) per share diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	55.80M	shares	1 Quarter
Weighted-average number of common shares used in computing net income (loss) per share diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	55.80M	shares	1 Quarter
Weighted-average number of common shares used in computing net income (loss) per share diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	58.43M	shares	1 Quarter
Weighted-average number of common shares used in computing net income (loss) per share diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	58.43M	shares	1 Quarter
Weighted-average number of common shares used in computing net income (loss) per share diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	57.58M	shares	3 Qtrs
Weighted-average number of common shares used in computing net income (loss) per share diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	57.58M	shares	3 Qtrs

Cash Flow Statement 164 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-91.32M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-91.32M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-96.12M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-96.12M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$947.91M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$947.91M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-81.02M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-81.02M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-81.55M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-81.55M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$770.25M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$770.25M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-83.81M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-83.81M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-256.15M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-256.15M	USD	3 Qtrs
Depreciation and amortization	`OtherDepreciationAndAmortization`	$4.29M	USD	3 Qtrs
Depreciation and amortization	`OtherDepreciationAndAmortization`	$4.29M	USD	3 Qtrs
Depreciation and amortization	`OtherDepreciationAndAmortization`	$5.22M	USD	3 Qtrs
Depreciation and amortization	`OtherDepreciationAndAmortization`	$5.22M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$30.95M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$30.95M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$31.94M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$31.94M	USD	3 Qtrs
Net accretion of discount on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$8.87M	USD	3 Qtrs
Net accretion of discount on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$8.87M	USD	3 Qtrs
Net accretion of discount on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$4.66M	USD	3 Qtrs
Net accretion of discount on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$4.66M	USD	3 Qtrs
(Gain) loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$39.00K	USD	3 Qtrs
(Gain) loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$39.00K	USD	3 Qtrs
(Gain) loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-278.00K	USD	3 Qtrs
(Gain) loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-278.00K	USD	3 Qtrs
Non-cash operating lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$8.57M	USD	3 Qtrs
Non-cash operating lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$8.57M	USD	3 Qtrs
Non-cash operating lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$7.97M	USD	3 Qtrs
Non-cash operating lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$7.97M	USD	3 Qtrs
Expense associated with license agreement	`ExpenseAssociatedWithLicenseAgreement`	-	USD	3 Qtrs
Expense associated with license agreement	`ExpenseAssociatedWithLicenseAgreement`	-	USD	3 Qtrs
Expense associated with license agreement	`ExpenseAssociatedWithLicenseAgreement`	$17.50M	USD	3 Qtrs
Expense associated with license agreement	`ExpenseAssociatedWithLicenseAgreement`	$17.50M	USD	3 Qtrs
Realized gain on investments	`RealizedInvestmentGainsLosses`	$28.00K	USD	3 Qtrs
Realized gain on investments	`RealizedInvestmentGainsLosses`	$28.00K	USD	3 Qtrs
Realized gain on investments	`RealizedInvestmentGainsLosses`	$168.00K	USD	3 Qtrs
Realized gain on investments	`RealizedInvestmentGainsLosses`	$168.00K	USD	3 Qtrs
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	-	USD	1 Quarter
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	-	USD	1 Quarter
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	$889.14M	USD	1 Quarter
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	$889.14M	USD	1 Quarter
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	-	USD	3 Qtrs
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	-	USD	3 Qtrs
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	$889.14M	USD	3 Qtrs
Gain on sale of contingent payments	`GainLossOnSaleOfContingentPayments`	$889.14M	USD	3 Qtrs
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	$200.00M	USD	3 Qtrs
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	$200.00M	USD	3 Qtrs
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	$200.00M	USD	1 Quarter
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	$200.00M	USD	1 Quarter
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	-	USD	3 Qtrs
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	-	USD	3 Qtrs
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Milestone payment from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$-1.03M	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$-1.03M	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$308.00K	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$308.00K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$7.35M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$7.35M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$8.78M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$8.78M	USD	3 Qtrs
Prepaid expenses and other current and non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$4.86M	USD	3 Qtrs
Prepaid expenses and other current and non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$4.86M	USD	3 Qtrs
Prepaid expenses and other current and non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-440.00K	USD	3 Qtrs
Prepaid expenses and other current and non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-440.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$7.36M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$7.36M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-5.20M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-5.20M	USD	3 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$140.00K	USD	3 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$140.00K	USD	3 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-9.86M	USD	3 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-9.86M	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$52.68M	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$52.68M	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	-	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	-	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-11.16M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-11.16M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-10.16M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-10.16M	USD	3 Qtrs
Other non-current liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-2.12M	USD	3 Qtrs
Other non-current liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-2.12M	USD	3 Qtrs
Other non-current liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	-	USD	3 Qtrs
Other non-current liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	-	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-223.57M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-223.57M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-256.67M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-256.67M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$327.49M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$327.49M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$1.34B	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$1.34B	USD	3 Qtrs
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$668.25M	USD	3 Qtrs
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$668.25M	USD	3 Qtrs
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$488.49M	USD	3 Qtrs
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$488.49M	USD	3 Qtrs
Payments associated with license agreement	`PaymentsAssociatedWithLicenseAgreement`	$17.50M	USD	3 Qtrs
Payments associated with license agreement	`PaymentsAssociatedWithLicenseAgreement`	$17.50M	USD	3 Qtrs
Payments associated with license agreement	`PaymentsAssociatedWithLicenseAgreement`	-	USD	3 Qtrs
Payments associated with license agreement	`PaymentsAssociatedWithLicenseAgreement`	-	USD	3 Qtrs
Proceeds from sale of contingent payments	`ProceedsFromSaleOfContingentPayments`	$889.14M	USD	3 Qtrs
Proceeds from sale of contingent payments	`ProceedsFromSaleOfContingentPayments`	$889.14M	USD	3 Qtrs
Proceeds from sale of contingent payments	`ProceedsFromSaleOfContingentPayments`	-	USD	3 Qtrs
Proceeds from sale of contingent payments	`ProceedsFromSaleOfContingentPayments`	-	USD	3 Qtrs
Proceeds from milestone payment from gain on sale of oncology business	`ProceedsFromMilestonePaymentFromGainOnSaleOfBusiness`	$200.00M	USD	3 Qtrs
Proceeds from milestone payment from gain on sale of oncology business	`ProceedsFromMilestonePaymentFromGainOnSaleOfBusiness`	$200.00M	USD	3 Qtrs
Proceeds from milestone payment from gain on sale of oncology business	`ProceedsFromMilestonePaymentFromGainOnSaleOfBusiness`	-	USD	3 Qtrs
Proceeds from milestone payment from gain on sale of oncology business	`ProceedsFromMilestonePaymentFromGainOnSaleOfBusiness`	-	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$718.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$718.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$765.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$765.00K	USD	3 Qtrs
Proceeds from sale of equipment	`ProceedsFromSaleOfMachineryAndEquipment`	$40.00K	USD	3 Qtrs
Proceeds from sale of equipment	`ProceedsFromSaleOfMachineryAndEquipment`	$40.00K	USD	3 Qtrs
Proceeds from sale of equipment	`ProceedsFromSaleOfMachineryAndEquipment`	$1.32M	USD	3 Qtrs
Proceeds from sale of equipment	`ProceedsFromSaleOfMachineryAndEquipment`	$1.32M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$412.60M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$412.60M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$144.06M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$144.06M	USD	3 Qtrs
Net proceeds from stock option exercises and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$4.59M	USD	3 Qtrs
Net proceeds from stock option exercises and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$4.59M	USD	3 Qtrs
Net proceeds from stock option exercises and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$9.60M	USD	3 Qtrs
Net proceeds from stock option exercises and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$9.60M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.59M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.59M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$9.60M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$9.60M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-74.93M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-74.93M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$165.53M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$165.53M	USD	3 Qtrs
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$139.26M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$139.26M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$253.73M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$253.73M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$88.20M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$88.20M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$64.33M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$64.33M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$139.26M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$139.26M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$253.73M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$253.73M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$88.20M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$88.20M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$64.33M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$64.33M	USD	Point-in-time
Additions to property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$61.00K	USD	3 Qtrs
Additions to property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$61.00K	USD	3 Qtrs
Additions to property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$14.00K	USD	3 Qtrs
Additions to property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$14.00K	USD	3 Qtrs
Net cash taxes (returned) paid	`IncomeTaxesPaidNet`	$1.59M	USD	3 Qtrs
Net cash taxes (returned) paid	`IncomeTaxesPaidNet`	$1.59M	USD	3 Qtrs
Net cash taxes (returned) paid	`IncomeTaxesPaidNet`	$-637.00K	USD	3 Qtrs
Net cash taxes (returned) paid	`IncomeTaxesPaidNet`	$-637.00K	USD	3 Qtrs

Stockholders Equity 102 line items

Line Item	Tag	Value	Unit	Period
Beginning balance (in shares)	`CommonStockSharesOutstanding`	55.95M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	55.95M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	57.02M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	57.02M	shares	Point-in-time
Beginning balance	`StockholdersEquity`	$964.24M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$964.24M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.10B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.10B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.04B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.04B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.63B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.63B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$743.92M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$743.92M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$886.84M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$886.84M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$660.51M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$660.51M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$811.02M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$811.02M	USD	Point-in-time
Treasury stock, beginning balance (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Treasury stock, beginning balance (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Treasury stock, beginning balance (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Treasury stock, beginning balance (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$-4.12M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$-4.12M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$459.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$459.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$-2.97M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$-2.97M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$-42.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$-42.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$-4.46M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$-4.46M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$646.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$646.00K	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	223,740.00	shares	3 Qtrs
Common stock issued under stock incentive plan and ESPP (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	223,740.00	shares	3 Qtrs
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.47M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.47M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.88M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.88M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$5.86M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$5.86M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.64M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.64M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$238.00K	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$238.00K	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.10M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.10M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$10.14M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$10.14M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$9.08M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$9.08M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.14M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.14M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.56M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.56M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$9.23M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$9.23M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.74M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.74M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-91.32M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-91.32M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-96.12M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-96.12M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$947.91M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$947.91M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-81.02M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-81.02M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-81.55M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-81.55M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$770.25M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$770.25M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-83.81M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-83.81M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-256.15M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-256.15M	USD	3 Qtrs
Ending balance (in shares)	`CommonStockSharesOutstanding`	55.95M	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	55.95M	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	57.02M	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	57.02M	shares	Point-in-time
Ending balance	`StockholdersEquity`	$964.24M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$964.24M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.10B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.10B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.04B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.04B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.63B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.63B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$743.92M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$743.92M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$886.84M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$886.84M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$660.51M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$660.51M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$811.02M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$811.02M	USD	Point-in-time
Treasury stock, ending balance (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Treasury stock, ending balance (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Treasury stock, ending balance (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Treasury stock, ending balance (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time

Comprehensive Income 32 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-91.32M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-91.32M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-96.12M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-96.12M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$947.91M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$947.91M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-81.02M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-81.02M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-81.55M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-81.55M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$770.25M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$770.25M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-83.81M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-83.81M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-256.15M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-256.15M	USD	3 Qtrs
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$4.46M	USD	1 Quarter
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$4.46M	USD	1 Quarter
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$3.86M	USD	3 Qtrs
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$3.86M	USD	3 Qtrs
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$2.97M	USD	1 Quarter
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$2.97M	USD	1 Quarter
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$6.64M	USD	3 Qtrs
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$6.64M	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-88.35M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-88.35M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$774.11M	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$774.11M	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-249.51M	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-249.51M	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$952.38M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$952.38M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.